Reid Schindler, M.D., presented positive Phase I data from a human study designed to assess a new investigational therapy to treat Wet Age-related Macular Degeneration (Wet AMD), the leading cause of vision loss and blindness. Salutaris Medical Devices, Inc. (SalutarisMD™) developed the minimally invasive device and sponsored the study.
Maui, Hawai - At Retina Meeting 2012 today, Reid Schindler, M.D., presented positive Phase I data from a human study designed to assess a new investig ...
Satisfied Users & 
Approved Press Releases
